EASL Podcasts

In this episode, we discuss the first pig-to-human liver xenotransplantation and the breakthroughs behind the revival of xenotransplantation, examining its potential and remaining challenges. We also explore the accelerating field of machine perfusion, clarifying different approaches and reviewing the evidence supporting their role in organ assessment, optimisation, and DCD utilisation.
Host: Sarwa Darwish Murad (Erasmus University Rotterdam)
Speakers: Jeroen de Jonge (Erasmus University Rotterdam) and Matthew Armstrong (University Hospital Birmingham)
This episode is also available on EASL Campus: https://easlcampus.eu/tltm/episode-09

Spontaneous bacterial peritonitis (SBP) remains a major complication of cirrhosis - but rising antimicrobial resistance and emerging data are challenging long-standing practices.
In this episode, we review current evidence on primary and secondary prophylaxis, resistance patterns, albumin use, and treatment strategies. How should clinicians balance prevention with antimicrobial stewardship? And where might practice need to evolve in 2026?
Host: Thomas Marjot (King's College London)
Speakers:  Bogdan Procopet (Institute of Gastroenterology and Hepatology, Cluj-Napoca) and Alastair O'Brien (Royal Free Hospital, London) 
This episode is also available on EASL Campus: https://easlcampus.eu/tltm/episode-08

In this EASL DeepDive webinar, the expert panel presents and explains the key studies behind the latest recommendations included in the EASL Clinical Practice Guidelines on the management of extrahepatic cholangiocarcinoma.
Learning Objectives
To identify patients at risk for eCCA, and review the current tools and strategies for its surveillance, diagnosis, staging, and classification
To define the optimal candidates for resection and liver transplantation, and discuss challenges in the surgical management of eCCA
To discuss the role of systemic therapy in the management of eCCA across all disease stages (including neoadjuvant, adjuvant, and palliative settings)
Faculty
Luca Maroni - Moderator
Julie Heimbach - Speaker
Anna Saborowski - Speaker
Lars Aabakken - Speaker

This episode explores the role of lifestyle in preventing and managing liver disease, including MASLD/MASH. Our experts discuss the impact of diet and physical activity, why lifestyle change can be difficult to start and sustain, and why small, achievable steps can still make a meaningful difference. 
Host: Cyrielle Caussy
Speakers:  Kate Hallsworth and Manuel Romero-Gómez 
This episode is also available on EASL Campus: https://easlcampus.eu/tltm/episode-07

Hepatocellular carcinoma (HCC) is responsible for 75% of all primary liver cancers and is the third most prevalent cause of cancer death worldwide, with 900,000 new cases diagnosed each year. Many patients are diagnosed at an advanced stage, making curative treatment difficult.
In this DeepDive Webinar, you’ll be guided through the latest advances in hepatocellular carcinoma management, from the rising impact of immunotherapy combinations to evolving approaches in intermediate-stage disease. 
This EASL DeepDive webinar is supported by Bayer AG. Bayer AG has had no input into the content of this EASL DeepDive.
Learning Objectives
What are strategies to optimise surveillance and early diagnosis of hepatocellular carcinoma
What are the optimal candidates for surgery (including liver transplantation) and locoregional therapies (alone or combined with immunotherapy)
Optimal selection of systemic front-line regimens and treatment sequencing after first-line immunotherapy
Faculty
Manon Allaire - Moderator
Fabio Piscaglia - Speaker
Antonio D'Alessio - Speaker
Anna Saborowski - Speaker